BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

723 related articles for article (PubMed ID: 29124439)

  • 21. The efficacy and tolerability of pharmacologic treatment options for Lennox-Gastaut syndrome.
    Montouris GD; Wheless JW; Glauser TA
    Epilepsia; 2014 Sep; 55 Suppl 4():10-20. PubMed ID: 25284033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after callosotomy or vagus nerve stimulation in consecutive prospective cohorts of children with Lennox-Gastaut or Lennox-like syndrome and non-specific MRI findings.
    Cukiert A; Cukiert CM; Burattini JA; Lima AM; Forster CR; Baise C; Argentoni-Baldochi M
    Seizure; 2013 Jun; 22(5):396-400. PubMed ID: 23490456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.
    Cramer JA; Sapin C; François C
    Acta Neurol Scand; 2013 Aug; 128(2):91-9. PubMed ID: 23410109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Lennox-Gastaut Syndrome (LGS).
    Ferrie CD; Patel A
    Eur J Paediatr Neurol; 2009 Nov; 13(6):493-504. PubMed ID: 19211283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epilepsy in Christianson syndrome: Two cases of Lennox-Gastaut syndrome and a review of literature.
    Ikeda A; Yamamoto A; Ichikawa K; Tsuyusaki Y; Tsuji M; Iai M; Enomoto Y; Murakami H; Kurosawa K; Miyatake S; Matsumoto N; Goto T
    Epilepsy Behav Rep; 2020; 13():100349. PubMed ID: 31879735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rufinamide for the treatment of Lennox-Gastaut syndrome.
    Besag FM
    Expert Opin Pharmacother; 2011 Apr; 12(5):801-6. PubMed ID: 21348771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome.
    He N; Li BM; Li ZX; Wang J; Liu XR; Meng H; Tang B; Bian WJ; Shi YW; Liao WP
    J Neurodev Disord; 2018 Mar; 10(1):10. PubMed ID: 29558884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
    McCormack PL
    Pharmacoeconomics; 2012 Mar; 30(3):247-56. PubMed ID: 22332960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilepsy Surgery is a Viable Treatment for Lennox Gastaut Syndrome.
    Keator CG
    Semin Pediatr Neurol; 2021 Jul; 38():100894. PubMed ID: 34183143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis.
    Lancman G; Virk M; Shao H; Mazumdar M; Greenfield JP; Weinstein S; Schwartz TH
    Seizure; 2013 Jan; 22(1):3-8. PubMed ID: 23068970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
    Striano P; McMurray R; Santamarina E; Falip M
    Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia.
    You SJ; Lee JK; Ko TS
    Brain Dev; 2007 Apr; 29(3):167-70. PubMed ID: 17005346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic approach to Lennox-Gastaut syndrome: a systematic review.
    Borrelli S; El Tahry R
    Acta Neurol Belg; 2019 Sep; 119(3):315-324. PubMed ID: 31286465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.
    Ostendorf AP; Ng YT
    Neuropsychiatr Dis Treat; 2017; 13():1131-1140. PubMed ID: 28461749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Lennox-Gastaut syndrome.
    Hancock EC; Cross JH
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003277. PubMed ID: 23450537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conceptualizing lennox-gastaut syndrome as a secondary network epilepsy.
    Archer JS; Warren AE; Jackson GD; Abbott DF
    Front Neurol; 2014; 5():225. PubMed ID: 25400619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketogenic diet in patients with Lennox-Gastaut syndrome.
    Caraballo RH; Fortini S; Fresler S; Armeno M; Ariela A; Cresta A; Mestre G; Escobal N
    Seizure; 2014 Oct; 23(9):751-5. PubMed ID: 25011392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of treatment patterns and healthcare costs associated with probable Lennox-Gastaut syndrome.
    Piña-Garza JE; Montouris GD; Vekeman F; Cheng WY; Tuttle E; Giguere-Duval P; Duh MS; Shen V; Saurer TB; Isojarvi J
    Epilepsy Behav; 2017 Aug; 73():46-50. PubMed ID: 28609734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lennox Gastaut Syndrome - A strategic shift in diagnosis over time?
    Evans NJ; Das K
    Seizure; 2022 Dec; 103():68-71. PubMed ID: 36332460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.